[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BridgeBio Pharma, Inc. Common Stock (BBIO)

BridgeBio Pharma (BBIO) hits a 1-year high driven by positive clinical data and potential M&A interest. Influential creators are mentioning the stock with high engagement.

About BridgeBio Pharma, Inc. Common Stock

BridgeBio Pharma, Inc. Common Stock (BBIO) is a biotechnology company focused on developing and delivering medicines for genetic diseases and cancers.
BridgeBio Pharma, Inc. Common Stock uses the ticker $BBIO for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

BridgeBio Pharma, Inc. Common Stock Price hit a high of XXXXX for the hour
BridgeBio Pharma, Inc. Common Stock Price hit an all time of XXXXX for the hour

Price: $XXXXX #

Price 24-Hour Chart Data
The stock price is at a 1-year high, up XXXX% in the last XX hours, fueled by positive sentiment from clinical data, growth potential, and potential M&A activity, as many social posts suggest. The surge in social dominance, engagements, and market cap further supports the positive price action.

24-Hour	7-Day	30-Day
-XXXX%	XXXX%	XXXXX%

1-Year High: $XXXXX on 2025-07-14
1-Year Low: $XXXXX on 2024-11-18

AltRank: XXXXX #

AltRank Line Chart
AltRank 24-Hour Chart Data
BridgeBio Pharma, Inc. Common Stock (BBIO) is currently AltRank #1,024 based on combined combined social and market metrics Daily Average: XXX
1 Week: XXXXX +434
1 Month: XXXXX -XX
6 Months: XXXXX +721
1 Year: XXXXX +286
1-Year High: XXXXX on 2025-05-28
1-Year Low: X on 2024-11-24

Galaxy Score: XXXXX #

Galaxy Score Line Chart
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +4
1 Month: XX -XX
6 Months: XX -X
1 Year: XX +31
1-Year High: XX on 2025-02-04
1-Year Low: X on 2024-10-15

Engagements: XXXXXX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Week: XXXXXXX -XX%
1 Month: XXXXXXX +42%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXXX +98%
1-Year High: XXXXXXX on 2024-11-25
1-Year Low: XXX on 2024-12-27

Social Network	X	Reddit
Engagements	XXXXXX	X

Mentions: XXX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXXXX +256%
6 Months: XXXXX -XX%
1 Year: XXXXX +209%
1-Year High: XXX on 2024-11-25
1-Year Low: XX on 2024-07-31

Social Network	X	Reddit
Mentions	XXX	X

Creators: XX #

Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning BridgeBio Pharma, Inc. Common Stock (BBIO) in the last XX hours which is down XXXX% from XX in the previous XX hours Daily Average: XX
1 Week: XXX -XX%
1 Month: XXXXX +501%
6 Months: XXXXX +27%
1 Year: XXXXX +261%
1-Year High: XXX on 2024-11-26
1-Year Low: XX on 2024-07-31

The most influential creators that mention BridgeBio Pharma, Inc. Common Stock in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@Andre_AGTC	X	XXXXX	X	XXX

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -XX%
6 Months: XX% -X%
1 Year: XX% +9%
1-Year High: XXX% on 2024-07-31
1-Year Low: XX% on 2024-11-01

Most Supportive Themes

Positive Clinical Data: (36%) Positive clinical data, particularly regarding Acoramidis, are driving optimism among investors.
Commercial Viability and Growth Potential: (31%) Analysts and investors express confidence in BridgeBio's commercial viability and potential for growth.
Acquisition Potential and Industry Comparisons: (21%) Comparisons to other successful biotech companies and mentions of potential M&A activity suggest a positive outlook.

Most Critical Themes

Competition and Market Challenges: (7%) Concerns about competition from established players in the market.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXXXX	XX%	XXXXX	XX%	XXXXX	XX%
Reddit	X	X%	X	X%	X	X%

Total	XXXXX	XX%	XXXXX	XX%	XXXXX	XX%

Social Dominance: XXXXX% #

Social Dominance Line Chart
Social Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: XXXX%
1 Week: XXXXX% -XXXXXXX%
1 Month: XXXX% -XXXX%
6 Months: XXXX% -XXXXX%
1 Year: XXXX% +0.011%
1-Year High: XXXX% on 2024-11-25
1-Year Low: XXXXXX% on 2024-07-31

Market Dominance: XXXXX% #

Market Dominance Line Chart
Market Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-09-07
1-Year Low: XXXXXXX% on 2025-03-11

Market Cap: $XXXXXXXXXXXXX #

Market Cap Line Chart
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$0.09%
1 Month: $XXXXXXXXXXXXX +$16%
6 Months: $XXXXXXXXXXXXX +$38%
1 Year: $XXXXXXXXXXXXX +$82%
1-Year High: $XXXXXXXXXXXXX on 2025-07-14
1-Year Low: $XXXXXXXXXXXXX on 2024-11-18

Top assets mentioned In the posts about BridgeBio Pharma, Inc. Common Stock in the last XX hours

Alnylam Pharmaceuticals, Inc. (ALNY) Bitcoin Incognito (XBI) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Alnylam Pharmaceuticals, Inc. (ALNY) Pfizer, Inc. (PFE) SuperRare (RARE) TG Therapeutics, Inc. (TGTX) Akropolis (AKRO) Insmed, Inc. (INSM)

Top topics mentioned In the posts about BridgeBio Pharma, Inc. Common Stock in the last XX hours

$alny, $xbi, $vrna, stocks, nvda, stocks healthcare, avgo, pfe, ibkr, $mdgl, alnylam pharmaceuticals inc, $1211hk, byd, amzn, $jcap, msft, hood, $ppta, asts, $ptn, $pfe, oust, $rare, $tgtx, rklb, acquisition, pltr, coins healthcare, alt, $nktr, balance sheet, aes, $akro, qqq, spx, $mirm, $insm, investment, nxt, $mgx, $prme, $veon, sap, op, $srpt, ndaq, $vktx, ske, $bpmc, $mreo, $edit, $bk, $atat, $cdtx, $qntm, $lyel, $byd, $vrtx, srm, jpm, meta, insp, $hik, $prm, coins energy, $xers, baba, $nvs, $argx, sonn, united states, cfg, ltc, $tern, Sentiment, $imcr, $nbix, realworld, $20b, $4b, $psnl, $twnp, hwm, mstr, dawn, $itci, telo, $300m, $asnd, $bayzf, stx, drugs, $rckt, $tlx, nem, ego, $txn, bla, mira, $ipsc